BOTTI, ELISABETTA

BOTTI, ELISABETTA  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 57 (tempo di esecuzione: 0.02 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
3-mag-2010 A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A Articolo su rivista
1-gen-2012 Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis Hundhausen, C; Bertoni, A; Mak, Rk; Botti, E; Di Meglio, P; Clop, A; Laggner, U; Chimenti, S; Hayday, Ac; Barker, Jn; Trembath, Rc; Capon, F; Nestle, Fo Articolo su rivista
1-gen-2018 Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA Frasca, L; Palazzo, R; Chimenti, Ms; Alivernini, S; Tolusso, B; Bui, L; Botti, E; Giunta, A; Bianchi, L; Petricca, L; Auteri, Se; Spadaro, F; Fonti, Gl; Falchi, M; Evangelista, A; Marinari, B; Pietraforte, I; Spinelli, Fr; Colasanti, T; Alessandri, C; Conti, F; Gremese, E; Costanzo, A; Valesini, G; Perricone, R; Lande, R Articolo su rivista
1-gen-2008 Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) Botti, E; Hundhausen, C; Laggner, U; DI MEGLIO, P; Marget, M; Chimenti, S; Nestle, Fo Intervento a convegno
29-mar-2019 Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis Caposiena Caro, Rd; Di Prete, M; Didona, D; Botti, E; Orlandi, A; Bianchi, L Articolo su rivista
1-gen-2019 Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations Caposiena Caro, Rd; Cannizzaro, Mv; Botti, E; Di Raimondo, C; Di Matteo, E; Gaziano, R; Bianchi, L Articolo su rivista
1-dic-2011 Confocal, wide band spectral reflection microscope, and relevant spectral imaging method Romana Bertani, F; Botti, E; Cilloco, F; Costanzo, A; Ferrari, L; Selci, S Brevetti
11-ott-2020 Cutaneous mastocytosis: a dermatological perspective Di Raimondo, C; Del Duca, E; Silvaggio, D; Di Prete, M; Lombardo, P; Mazzeo, M; Spallone, G; Campione, E; Botti, E; Bianchi, L Articolo su rivista
1-set-2012 Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A Intervento a convegno
1-gen-2019 CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis Lande, R; Lee, Ey; Palazzo, R; Marinari, B; Pietraforte, I; Santos, Gs; Mattenberger, Y; Spadaro, F; Stefanantoni, K; Iannace, N; Dufour, Am; Falchi, M; Bianco, M; Botti, E; Bianchi, L; Alvarez, M; Riccieri, V; Truchetet, M; C L Wong, G; Chizzolini, C; Frasca, L Articolo su rivista
1-nov-2014 Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2011 Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, Pd; De Nicola, F; Ganci, F; Castrignano, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A Articolo su rivista
23-mag-2020 Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report Mazzilli, S; Cosio, T; Botti, E; Petruzzellis, A; Lanna, C; Diluvio, L; Bianchi, L; Campione, E Articolo su rivista
1-gen-2019 Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model Fratoddi, I; Benassi, L; Botti, E; Vaschieri, C; Venditti, I; Bessar, H; Samir, Ma; Azzoni, P; Magnoni, C; Costanzo, A; Casagrande, V; Federici, M; Bianchi, L; Pellacani, G Articolo su rivista
1-gen-2009 Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S Articolo su rivista
1-gen-2009 Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S Articolo su rivista
1-gen-2013 Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2016 Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis Bessar, H; Venditti, I; Benassi, L; Vaschieri, C; Azzoni, P; Pellacani, G; Magnoni, C; Botti, E; Casagrande, V; Federici, M; Costanzo, A; Fontana, L; Testa, G; Mostafa, F; Ibrahim, S; Russo, M; Fratoddi, I Articolo su rivista
1-dic-2015 Genetic markers predictive of clinical response to biological drugs in psoriasis. Marinari, B; Talamonti, M; Costanzo, A; Botti, E Brevetti
1-mag-2013 Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A Intervento a convegno